BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 17555461)

  • 1. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer.
    Ghazale A; Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Clain JE; Pearson RK; Pelaez-Luna M; Petersen BT; Vege SS; Farnell MB
    Am J Gastroenterol; 2007 Aug; 102(8):1646-53. PubMed ID: 17555461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
    Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
    Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basic and clinical studies for IgG4 measurement by nephelometric immunoassay].
    Kameko M; Kitamura H; Kawa S; Hamano H; Arai J
    Rinsho Byori; 2010 Apr; 58(4):393-6. PubMed ID: 20496768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis.
    Talar-Wojnarowska R; Gąsiorowska A; Olakowski M; Dranka-Bojarowska D; Lampe P; Śmigielski J; Kujawiak M; Grzegorczyk J; Małecka-Panas E
    Adv Med Sci; 2014 Sep; 59(2):288-92. PubMed ID: 25194335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis.
    Kamisawa T; Imai M; Egawa N; Tsuruta K; Okamoto A
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1167-70. PubMed ID: 18936710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new diagnostic endoscopic tool for autoimmune pancreatitis.
    Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A
    Gastrointest Endosc; 2008 Aug; 68(2):358-61. PubMed ID: 18513718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IgG4 concentrations and IgG4-related sclerosing disease.
    Tabata T; Kamisawa T; Takuma K; Anjiki H; Egawa N; Kurata M; Honda G; Tsuruta K; Setoguchi K; Obayashi T; Sasaki T
    Clin Chim Acta; 2009 Oct; 408(1-2):25-8. PubMed ID: 19580797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis.
    Dhall D; Suriawinata AA; Tang LH; Shia J; Klimstra DS
    Hum Pathol; 2010 May; 41(5):643-52. PubMed ID: 20149413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
    Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Zhang L; Clain JE; Pearson RK; Petersen BT; Vege SS; Farnell MB
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1010-6; quiz 934. PubMed ID: 16843735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG4+ to IgG+ plasma cells ratio of ampulla can help differentiate autoimmune pancreatitis from other "mass forming" pancreatic lesions.
    Sepehr A; Mino-Kenudson M; Ogawa F; Brugge WR; Deshpande V; Lauwers GY
    Am J Surg Pathol; 2008 Dec; 32(12):1770-9. PubMed ID: 18779730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined measurement of total serum IgG and IgG4 may increase diagnostic sensitivity for autoimmune pancreatitis without sacrificing specificity, compared with IgG4 alone.
    Song TJ; Kim MH; Moon SH; Eum JB; Park DH; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2010 Jul; 105(7):1655-60. PubMed ID: 20010924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential value of serum total IgE for differentiation between autoimmune pancreatitis and pancreatic cancer.
    van Toorenenbergen AW; van Heerde MJ; van Buuren HR
    Scand J Immunol; 2010 Nov; 72(5):444-8. PubMed ID: 21039739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patchy distribution of pathologic abnormalities in autoimmune pancreatitis: implications for preoperative diagnosis.
    Chandan VS; Iacobuzio-Donahue C; Abraham SC
    Am J Surg Pathol; 2008 Dec; 32(12):1762-9. PubMed ID: 18779731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of serum IgG4 in Western patients with autoimmune sclerosing pancreatocholangitis: a word of caution.
    Hochwald SN; Hemming AW; Draganov P; Vogel SB; Dixon LR; Grobmyer SR
    Ann Surg Oncol; 2008 Apr; 15(4):1147-54. PubMed ID: 18219538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical usefulness of serum immunoglobulin G and G4 level in the diagnosis of autoimmune pancreatitis].
    Kang P; Lee KT; Sinn DH; Kim BJ; Lee JS; Lee JK; Rhee JC
    Korean J Gastroenterol; 2008 Nov; 52(5):304-9. PubMed ID: 19077477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune pancreatitis: a systemic immune complex mediated disease.
    Deshpande V; Chicano S; Finkelberg D; Selig MK; Mino-Kenudson M; Brugge WR; Colvin RB; Lauwers GY
    Am J Surg Pathol; 2006 Dec; 30(12):1537-45. PubMed ID: 17122509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IgG4 elevation in pancreatic cancer: diagnostic and prognostic significance and association with autoimmune pancreatitis.
    Ngwa T; Law R; Hart P; Smyrk TC; Chari ST
    Pancreas; 2015 May; 44(4):557-60. PubMed ID: 25785724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
    Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
    Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients.
    Kaji R; Takedatsu H; Okabe Y; Ishida Y; Sugiyama G; Yonemoto K; Mitsuyama K; Tsuruta O; Sata M
    J Gastroenterol Hepatol; 2012 Feb; 27(2):268-72. PubMed ID: 21929654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma.
    Wakabayashi T; Kawaura Y; Satomura Y; Watanabe H; Motoo Y; Okai T; Sawabu N
    Am J Gastroenterol; 2003 Dec; 98(12):2679-87. PubMed ID: 14687817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.